Neeta Balkrishan Amin

Title: Neeta Balkrishan Amin: Innovator in Fatty Liver Disease Treatment

Introduction

Neeta Balkrishan Amin is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of medicine, particularly in the treatment of fatty liver disease. Her innovative approach has led to the development of a unique therapeutic method that addresses critical health issues.

Latest Patents

Neeta holds a patent for her invention titled "Combinations for treatment of NAFLD/NASH and related diseases." This patent describes a method for treating fatty liver disease and related disorders using a therapeutically effective amount of a specific composition. The composition includes from about 25 mg to about 1200 mg of (S)-2-(5-((3-ethoxypyridin-2-yl)oxy)pyridin-3-yl)-N-(tetrahydrofuran-3-yl)pyrimidine-5-carboxamide or a pharmaceutically acceptable salt thereof, along with from about 5 mg to about 40 mg of 4-(4-(1-Isopropyl-7-oxo-1,4,6,7-tetrahydrospiro[indazole-5,4'-piperidine]-1′-carbonyl)-6-methoxypyridin-2-yl)benzoic acid or a pharmaceutically acceptable salt thereof. This patent represents her innovative approach to addressing a significant health concern.

Career Highlights

Neeta is currently associated with Pfizer Corporation, where she continues to work on groundbreaking research and development in the pharmaceutical field. Her expertise and dedication have positioned her as a valuable asset in the fight against liver diseases.

Collaborations

Throughout her career, Neeta has collaborated with notable professionals in her field, including Arthur James Bergman and Roberto Arnaldo Calle. These collaborations have further enhanced her research and contributed to the advancement of medical treatments.

Conclusion

Neeta Balkrishan Amin is a trailblazer in the field of medical innovation, particularly in the treatment of fatty liver disease. Her contributions through her patent and work at Pfizer Corporation highlight her commitment to improving health outcomes.